生物制药上游行业技术壁垒高，客户粘性强。生物制药上游行业包括下游科研、研发、生产所需的仪器、设备、原料和耗材，涉及物理、材料、电子、生物等多学科交叉，该行业产品种类丰富，研发难度大，技术壁垒高。产品注册制度导致下游用户更换核心原料、生产设备的成本高、代价大，因此客户对上游供应商选择谨慎，用户粘性强，行业护城河宽。

2021年第三季度，中国医疗卫生行业继续扩张，居民人均医疗服务支出同比增长10.6%，出口同比激增158%。行业投资预计将持续增长，同时线上医疗领域的监管也将进一步改善。这一趋势既有助于满足疫情期间居民不断增长的医疗需求，也有助于平等分配国内城乡医疗资源。

There is a significant opportunity for growth of the global minimally invasive surgical systems market during the next ten years. The growth is mainly expected to be driven by the growth of the geriatric population across the globe, as well as that rise in the prevalence of chronic diseases. The adoption of advanced technologies such as robotic-assisted surgeries is also expected to be driven by increasing patient acceptance for sophisticated surgical procedures. The market in developing countries is expected to be propelled by the increasing capability of hospitals and other end users to install and maintain robotic-surgery systems. In terms of the conventional minimally invasive surgical systems market, the significant advantages over open surgeries are expected to increase the rate of adoption.

Soaps that are available in liquid form and are generally used for washing utensils; cleaning body parts such as hands, beard, and face; and scrubbing dirty surfaces are known as liquid soaps. These are available in different types as well as sizes that cater to the requirement of the customers. For the purpose of analysis, the liquid soap market is segmented into product type, type, application, Distribution channel, and region. The report covers a detailed analysis of the trends and future estimations, and offers a thorough study of the global market. This report further highlights the key areas of investment. It analyzes government regulations and policies to provide information on the current market trends in different regions and suggests the future growth opportunities. The report covers the overall net value of different products of liquid soap category consumed by various consumers across the globe. The study highlights Porter’s five forces analysis to determine the factors affecting the market growth. These factors include raw material prices, intense competition, end users, manufacturers, and suppliers. To understand the market, drivers, restraints, and opportunities are explained in the report. In addition, the study features the strategies adopted by key market players to maintain their foothold in the market. Furthermore, it highlights the competitive landscape of the key players to increase their market share and sustain intense competition in the industry.

Computed tomography (CT), X-ray, and ultrasound, though not the first choice for COVID-19 diagnoses, became important tools in managing COVID-19. Hence, these modalities generated better revenues than the others. Teleradiology witnessed major adoption as more practices shifted their work from hospitals to homes and home offices necessitated investments in hardware and software. Due to financial problems, efficiency and productivity became top priorities for hospital administration. Artificial intelligence (AI), cloud, and analytics were the major areas that received significant attention during the pandemic year.

Mental health includes our emotional, psychological, and social well-being. It affects how we think, feel, and act. It also helps determine how we handle stress, relate to others, and make choices. Mental health is important at every stage of life, from childhood and adolescence through adulthood. For the purpose of analysis, the mental health market is segmented into disorder, services, age group, and region. The market study provides the dynamics and trends of the global mental health market. It offers market estimations and forecasts for the mental health services such emergency mental health services, outpatient counselling, home-based treatment services, inpatient hospital treatment services, other services. However, it excludes the revenue generated from the drugs, consumables, and software used in mental health.

Monoclonal antibodies are used to improve & suppress the immune responses in several medical conditions and to treat different diseases such as cardiovascular, cancer, and cerebrovascular diseases. The benefits of monoclonal antibodies include inhibiting cancer cell growth, detecting & killing abnormal cells directly, and delivering radioactive particles to the specific cells, thereby decreasing the risk of side effects from medication. The report provides market dynamics and trends related to the monoclonal antibodies market. The study estimates the revenue generated from the sales of monoclonal antibodies sources. The valuations comprise revenue generated from monoclonal antibodies sources such as murine, chimeric, humanized, and human.

Mother & child healthcare market typically offers services such as pre-natal services, birthing services, postnatal services, and fertility services, which takes care of patients before and after pregnancy. The study estimates revenue generated from sales of mother & child healthcare services. The valuations comprise revenue generated from services such as pre-natal services, birthing services, post-natal services, and fertility services. This report, however, does not consider revenue generated by mother & child healthcare medications and costs of other medication involved in mother & child healthcare treatment.

The global surgical instrument tracking devices market is expected to grow at a CAGR of 9.16% for the forecast period 2021-2031. Leading market players strive to retain a competitive edge by having a good presence in key markets and offering a diverse product range. The market has witnessed a total of 32 key developments over the five years (January 2016-March 2021), with a majority of them being product offerings and upgradation accompanied by partnerships, alliances, and business expansions. Efforts are being made to bring more technologically innovative goods to market, each aimed at a particular unmet need. With the launch of new and updated devices with improved features, surgical instrument tracking devices technology has become increasingly possible to unlock new use cases.

The CRO market comprises services segmented into nonclinical and clinical based on the drug development stage. Some services, such as bioanalytical services, are peripheral services spanning both nonclinical and clinical drug development stages. This study focuses only on the broad core services in the CRO industry. The nonclinical segment includes drug discovery services and preclinical services. Further subsegments are not included in this study.

Artificial tears drug is used for the treatment of dry eye syndrome and allergic conjunctivitis. OTC artificial tears help to maintain moisture and well-being mostly in geriatric patients, who are vulnerable to dry eye syndrome due to intake of many medications and dysfunctions of lacrimal gland. This study comprises products only and not the services. The study estimates the revenue generated from the sales of OTC artificial tears. The valuations comprise revenue generated from adoption of OTC artificial tears by patients. The study scope focuses on OTC artificial drugs for hospital pharmacies, drug stores, and online pharmacies.

The research service will provide an overview of the global wound care solutions market, the competitive landscape, impact of COVID-19, and others. The geographical scope of this global study will be focused on three key regions namely, North America (NA), Europe, Asia-Pacific (APAC) and Rest of world (RoW). This study will provide a six-year global market revenue forecast from 2021 to 2026. This research service will offer a detailed segment analysis of the advanced wound care solutions, including the various next-generation solutions that are set to dominate the market. It will not cover basic and surgical wound care solutions. Wound care products related to pharmaceuticals and life sciences are also excluded from the study scope. The forecast for this study covers the wound care continuum approach comprising wound prevention and diagnosis solutions and wound management solutions.

The recent technological advancement in the field of next-generation sequencing (NGS) and cell and molecular biology has given birth to the new era of precision medicine, which offers a platform to analyze the variability in genes, lifestyle, and environment of each person individually. Now, the researchers have found an even better option through cell sequencing, which precedes the advancements of next-generation sequencing. In the past few decades, whole genome sequencing (WGS) and whole transcriptome sequencing (WTS) methods have been applied to single cells to combine DNA, RNA, protein, and chromatin information through a single cell. The transcriptomics technique has enabled researchers to use genomics, proteomics, transcriptomics, and epigenomics to understand the heterogeneity of genetically identical cells in the same tissue. The paradigm-shift from bulk cell sequencing to DR-seq (DNA and mRNA sequencing) and G&T-seq (genome and transcriptome), scM&T-seq (simultaneous single-cell methylome and transcriptome sequencing), scNMTseq (single-cell nucleosome, methylation, and transcription sequencing) enable to broaden the understanding of genotypic and phenotypic heterogeneity by using multi-omics approach. Information from different omics platforms can be integrated through this approach, making available deep insights on the effect of these omics’ layers on the underlying mechanisms of disease processes.

The increasing applications and benefits of confocal microscope and increasing adoption of confocal microscope is growing in biology, life science, material science, neuroanatomy, and neurophysiology, which is consequently expected to drive the growth of the market for confocal microscope over the forecast period. Rarely diagnosis and treatment of cases of microbial keratitis and along with clinical practices, confocal microscopy is developing into a powerful research and diagnostic tool in ophthalmology is further expected to spur the growth of the market for confocal microscope in the near future

The prevalence of several chronic diseases worldwide and the launch of sophisticated technologies and treatments have contributed to a rapid increase in healthcare expenses. Additionally, patients nowadays expect high-quality care at an affordable cost. Thus, it has become imperative for players in the healthcare industry to reduce the cost of their healthcare services while providing high-quality care to patients. Efficient healthcare logistics services provide a remarkable opportunity for controlling healthcare costs through the implementation of best practices. Moreover, the need for an effective flow of materials and information has been evident throughout history. In the healthcare business, materials and goods are always on the move. Hospitals and healthcare centers have huge central warehouses, small parts storage units, and everything in between. In healthcare warehousing, the biggest challenges entail supervising products with due dates, optimizing item titles, and enhancing processes while ordering supplies. Proper inventory management and the smooth movement of necessary healthcare products within the hospital premises may result in considerable savings instead of frequent new product orders.

新冠检测试剂主要分为核酸、抗原、抗体三种，其中抗原检测试剂操作简单、检测速度快，适用于大规模筛查场景，目前在疫情较严重的海外国家得到广泛应用。国产新冠检测试剂获得海内外广泛认证，截至2021年底我国已有超过700家企业的新冠检测试剂获得欧盟CE认证，近30家企业的产品获得美国EUA认证。

截至2021年11月12日，医药生物行业下跌6.4%，子版块医疗服务II上涨。医药板块分化，疫情受益及CXO板块表现突出，集采之下仿制药及高值。

我们对重点覆盖的53家医药上市公司2021    年度业绩进行预测。从增速看，预期Q4单季度业绩增速超过50%的有10 家，净利润增速在30%~50%的有10 家，净利润增速15%~30%的有9家，净利润增速0%~15%的有5家，净利润同比下滑的公司有11 家，还有8家公司由于基数、港股、亏损等原因未有Q4季度业绩增速。分板块看，CXO、疫苗核心公司全年业绩高增长。

北半球进入冬季，叠加Omicron，全球疫情持续。近期国内当日新增本土确诊病例数有所反复，全球新冠疫苗接种率持续提升；新冠小分子口服药物MPP 授权中低收入国家，未来该项目有望惠及全球中低收入国家新冠患者。

行业内规模最大的摩根大通健康医疗大会在线上进行，GSK、Pfizer、BMS 等国际巨头均有参与，国内众多药企也有参与，选取国内十三家药企的演讲内容进行精要总结，包含国内大药企的管线布局、国际化进展，Biotech 公司核心产品的战略规划、适应症布局、2022 年关键临床时间节点，以及未上市但具备差异化技术的公司。